Merck's Keytruda Fails to Meet Goal in Breast Cancer Trial

·

·

Merck's Keytruda Fails to Meet Goal in Breast Cancer Trial

Merck (MRK – Get Report) revealed that one of its key cancer-fighting drugs, Keytruda, failed to meet its stand-alone goal of treating an aggressive type of breast cancer. The drugmaker said Keytruda, among a class of medicines called PD-1 inhibitors, didn’t …
See Original Article

US Business Contributes Smallest Share of Taxes in Generation

U.S. corporations are contributing the smallest share of federal tax revenue in a generation. That's one of the findings in the Data Book for 2018,
See Original Article

Gold holds near two-week low as dollar and equities rise

(Reuters) – Gold fell on Tuesday, hovering near a more than two-week low touched in the previous session, as the dollar strengthened and improved risk appetite took the sheen off bullion ahead of the release of minutes from the U.S. Federal Reserve’s latest …
See Original Article

5 things you need to know now

House Oversight Chair Elijah Cummings (D-Md.) subpoenaed Trump's accounting firm last month. Trump's lawyers argued the requests were made
See Original Article

UK Factories See Flat Output Amid Stock Overhang, Weak Orders

U.K. manufacturers expect output to flat-line in the next three months in a hangover from the delay to Brexit. Factories stockpiled goods and ramped up production ahead of the original March 29 deadline to leave the European Union, but the latest survey from …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.